Please disable your adblock and script blockers to view this page

Bristol-Myers to buy Celgene in a $74 billion deal; Celgene shares surge


InBristol-Myers Squibb
Celgene
Juno Therapeutics
PlayingShare
CNBC
CNBC LLC
All Rights Reserved
Division
NBCUniversalData
Global Business and Financial News
Market Data and Analysis


Celgene
Giovanni Caforio
Watch Next

No matching tags

No matching tags

No matching tags

No matching tags

No matching tags

Positivity     37.00%   
   Negativity   63.00%
The New York Times
SOURCE: https://www.cnbc.com/2019/01/03/bristol-myers-to-buy-celgene-in-a-74-billion-deal.html
Write a review: CNBC
Summary

Bristol-Myers on Thursday announced plans to buy Celgene in a deal valued at $74 billion.

As said here by Berkeley Lovelace Jr.